Actionnariat et activité des initiés pour Viking Therapeutics, Inc. (VKTX): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $29.52 |
| Capitalisation | $3.4B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-01 | Kelly-Gemmell Dorothy Elizabeth | A-Award | 40,800 | $1.3M |
| 2026-08-01 | Kelly-Gemmell Dorothy Elizabeth | A-Award | 6,333 | |
| 2026-08-01 | Kelly-Gemmell Dorothy Elizabeth | |||
| 2026-07-28 | Lian Brian | A-Award | 221,667 | |
| 2026-07-29 | Lian Brian | S-Sale | 148,517 | $4.9M |
| 2026-07-28 | ZANTE GREG | A-Award | 31,667 | |
| 2026-07-29 | ZANTE GREG | S-Sale | 21,217 | $710K |
| 2026-07-28 | Mancini Marianna | A-Award | 31,667 | |
| 2026-07-29 | Mancini Marianna | S-Sale | 18,217 | $610K |
| 2026-06-01 | Chen Hubert C | A-Award | 190,000 | $5.9M |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $3.1M | $9.0M | $24.8M | $8.4M | $29.1M | $26.4M | $36.6M | $55.5M | $26.7M | $165.8M |
| Placements à Court Terme | $10.1M | $11.6M | $276.7M | $267.3M | $219.3M | $175.7M | $118.9M | $306.6M | $875.9M | $539.9M |
| Créances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $14.0M | $21.9M | $302.1M | $283.5M | $256.1M | $210.5M | $167.0M | $367.2M | $907.2M | $715.6M |
| Immobilisations Corporelles | 0 | 0 | 0 | $598000 | $321000 | $25000 | $1.4M | $1.1M | $1.0M | $85000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $14.5M | $22.1M | $302.3M | $284.3M | $256.5M | $210.7M | $168.5M | $368.5M | $908.3M | $715.7M |
| Dettes Fournisseurs | $1.2M | $1.5M | $959000 | $2.4M | $4.0M | $1.4M | $8.5M | $7.5M | $9.8M | $53.3M |
| Dette à Court Terme | $3.3M | $3.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $6.5M | $8.7M | $4.5M | $6.8M | $12.1M | $8.8M | $21.9M | $19.1M | $27.4M | $76.7M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $6.5M | $8.7M | $4.6M | $7.1M | $12.2M | $8.8M | $23.2M | $20.1M | $28.0M | $76.7M |
| Réserves | -$60.3M | -$80.9M | -$102.9M | -$128.7M | -$168.2M | -$223.2M | -$292.0M | -$377.9M | -$487.9M | -$847.5M |
| Capitaux Propres | $8.0M | $13.5M | $297.8M | $277.1M | $244.3M | $201.9M | $145.3M | $348.4M | $880.3M | $639.1M |
| Dette Totale | $3.3M | $3.5M | 0 | $662000 | $359000 | $29000 | $1.6M | $1.3M | $1.1M | $137000 |
| Dette Nette | -$9.9M | -$17.1M | -$301.5M | -$275.0M | -$248.0M | -$202.1M | -$153.9M | -$360.8M | -$901.5M | -$705.6M |
| Fonds de Roulement | $7.5M | $13.2M | $297.6M | $276.7M | $244.0M | $201.8M | $145.1M | $348.1M | $879.8M | $638.9M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 9.33 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 28.62 |
Rentabilité
| Rentabilité des capitaux propres | -56.28% |
| Rentabilité du capital investi | -61.54% |
| Rentabilité des actifs | -50.25% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: AAPG · ACAD · AKRO · CRNX · IMVT · KYMR · LGND
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de VKTX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions